TAK Takeda Pharmaceutical Company Limited ADRs

Takeda Pharmaceutical Co Ltd is a pharmaceutical company in Japan. It is primarily focused on four therapeutic areas; oncology, gastroenterology, cardiovascular/metabolic, and neurology. The company markets its products across Europe and emerging markets. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4502.

$17.13  +0.36 (2.15%)
As of 07/28/2021 16:00:02 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Japan
Country of incorporation:  
IPO date:  04/26/2000
Outstanding shares:  3,155,700,240
Average volume:  1,573,993
Market cap:   $53,141,992,042
Current dividend yield:  4.92%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    874060205
ISIN:        US8740602052
Valuation   (See tab for details)
PE ratio:   0.14
PB ratio:   0.01
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy